Inside PD-1/PD-L1,2 with their inhibitors - ScienceDirect Skip to main contentSkip to article
Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue Search …

Simple Summary Novel pharmacological approaches are needed to improve treatments of
advanced cancers, despite the considerable benefit of immunotherapy. New drugs are …

The limitations of current cancer therapies, including the increasing prevalence of multidrug
resistance, underscore the urgency for more effective treatments. One promising avenue lies …

Noncoding ribonucleic acids (ncRNAs) have surfaced as essential orchestrators within the
intricate system of neoplastic biology. Specifically, the epidermal growth factor receptor …

Background In recent years, drug screening has been one of the most significant challenges
in the field of personalized medicine, particularly in cancer treatment. However, several new …

Abstract Background Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha (PIP5K1A)
acts upstream of the Akt regulatory pathway and is abnormally expressed in many types of …

Drug repurposing, rebranding an existing drug for a new therapeutic indication, is deemed a
beneficial approach for a quick and cost-effective drug discovery process by skipping …

Hyperpigmentation is a common condition that causes darker spots or patches on the skin,
which often look brown, black, gray, red, or pink. This results in unresolved psychological …

Vitamin A, an essential micronutrient, is integral to various biological processes crucial for
organismal development and maintenance. Dietary sources of vitamin A encompass …

The exploration of non-cancer medications with potential anti-cancer activity offers a
promising avenue for drug repurposing, accelerating the development of new oncological …